PL3071248T3 - Materiały rusztowania tkankowego do regeneracji tkanki i sposoby ich wytwarzania - Google Patents

Materiały rusztowania tkankowego do regeneracji tkanki i sposoby ich wytwarzania

Info

Publication number
PL3071248T3
PL3071248T3 PL14863949T PL14863949T PL3071248T3 PL 3071248 T3 PL3071248 T3 PL 3071248T3 PL 14863949 T PL14863949 T PL 14863949T PL 14863949 T PL14863949 T PL 14863949T PL 3071248 T3 PL3071248 T3 PL 3071248T3
Authority
PL
Poland
Prior art keywords
tissue
making
methods
scaffold materials
regeneration
Prior art date
Application number
PL14863949T
Other languages
English (en)
Inventor
Jason Spector
Abraham D. Stroock
John Morgan
Original Assignee
Cornell University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell University filed Critical Cornell University
Publication of PL3071248T3 publication Critical patent/PL3071248T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PL14863949T 2013-11-19 2014-11-19 Materiały rusztowania tkankowego do regeneracji tkanki i sposoby ich wytwarzania PL3071248T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361906131P 2013-11-19 2013-11-19
PCT/US2014/066344 WO2015077300A1 (en) 2013-11-19 2014-11-19 Tissue scaffold materials for tissue regeneration and methods of making
EP14863949.5A EP3071248B1 (en) 2013-11-19 2014-11-19 Tissue scaffold materials for tissue regeneration and methods of making

Publications (1)

Publication Number Publication Date
PL3071248T3 true PL3071248T3 (pl) 2021-03-08

Family

ID=53180089

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14863949T PL3071248T3 (pl) 2013-11-19 2014-11-19 Materiały rusztowania tkankowego do regeneracji tkanki i sposoby ich wytwarzania

Country Status (12)

Country Link
US (3) US9968708B2 (pl)
EP (2) EP3785742A1 (pl)
JP (2) JP6618898B2 (pl)
KR (1) KR102180497B1 (pl)
CN (1) CN105916528A (pl)
AU (1) AU2014353110B2 (pl)
CA (1) CA2929611C (pl)
DK (1) DK3071248T3 (pl)
ES (1) ES2826392T3 (pl)
IL (2) IL273135B2 (pl)
PL (1) PL3071248T3 (pl)
WO (1) WO2015077300A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3071248T3 (da) * 2013-11-19 2020-11-09 Univ Cornell Vævsstilladsmateriale til vævsregenerering og fremgangsmåder til fremstilling
EP3182985B1 (en) 2014-08-20 2020-01-08 Silk Technologies Ltd. Fibroin-derived protein composition
WO2016200201A1 (ko) * 2015-06-12 2016-12-15 서울대학교산학협력단 귀 재건 및 재건의 필요성을 위한 장치 및 방법
EP3165240A1 (en) * 2015-11-05 2017-05-10 Ecole Polytechnique Federale De Lausanne (Epfl) Natural polymer-derived scaffold material and methods for production thereof
JP2018533596A (ja) 2015-11-12 2018-11-15 グレイバグ ビジョン インコーポレイテッド 医学療法のための凝集マイクロ粒子
WO2017162823A1 (en) * 2016-03-23 2017-09-28 Universiteit Gent Use of poly(alkylene terephthalates) and methods for their preparation
AU2017267370B2 (en) 2016-04-08 2021-07-08 Cornell University A method to enhance wound healing using silk-derived protein
WO2018031973A1 (en) 2016-08-12 2018-02-15 Silk Technologies, Ltd. Silk-derived protein for treating inflammation
JP7217022B2 (ja) 2017-03-23 2023-02-02 グレイバグ ビジョン インコーポレイテッド 眼障害の治療のための薬物及び組成物
MX2019013363A (es) 2017-05-10 2020-01-13 Graybug Vision Inc Microparticulas de liberacion extendida y suspensiones de las mismas para terapia medica.
JP7235392B2 (ja) * 2017-05-30 2023-03-08 アクファー アイピー ビー．ヴィー． ポリ（１，３－トリメチレンカーボネート）を含む再吸収性の生分解性医療用及び化粧品組成物
CN108144127B (zh) * 2018-01-25 2020-12-22 南京医科大学附属口腔医院 纤维蛋白凝胶/聚乳酸-羟基乙酸微球支架及其制备方法和应用
CN110559474A (zh) * 2019-09-09 2019-12-13 苏州汇涵医用科技发展有限公司 液体伤口敷料及其制备方法和使用
CN111166934A (zh) * 2020-01-13 2020-05-19 山东建筑大学 一种用于体内杀菌且提高生物软骨组织修复性能的方法
CN113144275B (zh) * 2020-01-22 2023-02-28 鸡西代悦科技有限公司 一种水凝胶粘合剂及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2281861B (en) * 1993-09-21 1997-08-20 Johnson & Johnson Medical Bioabsorbable wound implant materials containing microspheres
FR2780730B1 (fr) 1998-07-01 2000-10-13 Corneal Ind Compositions biphasiques injectables, notamment utiles en chirurgies reparatrice et esthetique
US8070827B2 (en) 2007-07-03 2011-12-06 Histogenics Corporation Method for use of a double-structured tissue implant for treatment of tissue defects
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
US20090202642A1 (en) * 2008-02-08 2009-08-13 Xiao Huang Drug Delivery System Comprising Microparticles and Gelation System
US8652500B2 (en) * 2009-07-22 2014-02-18 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
FR2955258A1 (fr) 2010-01-20 2011-07-22 Biopharmex Holding Ltd Composition injectable
US9682035B2 (en) * 2012-02-23 2017-06-20 The Board Of Trustees Of The Leland Stanford Junior University Injectable hydrogel system to modulate host response at bone implant interface
DK3071248T3 (da) * 2013-11-19 2020-11-09 Univ Cornell Vævsstilladsmateriale til vævsregenerering og fremgangsmåder til fremstilling
CN109805958B (zh) 2019-02-22 2021-03-16 无锡海斯凯尔医学技术有限公司 超声成像设备

Also Published As

Publication number Publication date
US20160287755A1 (en) 2016-10-06
IL273135A (en) 2020-04-30
CA2929611C (en) 2021-08-03
EP3071248A4 (en) 2017-07-12
AU2014353110A1 (en) 2016-05-26
JP2016538035A (ja) 2016-12-08
KR102180497B1 (ko) 2020-11-18
EP3071248A1 (en) 2016-09-28
EP3785742A1 (en) 2021-03-03
KR20160110935A (ko) 2016-09-23
IL273135B1 (en) 2023-07-01
US10953135B2 (en) 2021-03-23
JP7340374B2 (ja) 2023-09-07
CA2929611A1 (en) 2015-05-28
EP3071248B1 (en) 2020-08-05
IL245449B (en) 2020-03-31
AU2014353110B2 (en) 2018-05-10
ES2826392T3 (es) 2021-05-18
JP6618898B2 (ja) 2019-12-11
CN105916528A (zh) 2016-08-31
US20180289863A1 (en) 2018-10-11
US9968708B2 (en) 2018-05-15
US20220016319A1 (en) 2022-01-20
IL273135B2 (en) 2023-11-01
IL245449A0 (en) 2016-06-30
WO2015077300A1 (en) 2015-05-28
JP2019195675A (ja) 2019-11-14
DK3071248T3 (da) 2020-11-09

Similar Documents

Publication Publication Date Title
IL273135A (en) Tissue skeletal materials for tissue regeneration and methods of preparation
HUS2200048I1 (hu) FcRn antagonisták és alkalmazásaik
HRP20170888T1 (hr) Spoj tubulisina, metode pripreme i primjena
HK1219975A1 (zh) 用於病毒生產的細胞系和使用方法
GB2535360B (en) Methods of preparing polyhemiaminals and polyhexahydrotriazines
EP2999474A4 (en) THERAPEUTIC AND METHOD OF USE
EP2976044A4 (en) COMPOSITIONS AND METHODS FOR PROMOTING REGENERATION OF DENTAL TISSUE
EP2971292A4 (en) ELECTROSPINNING DEVICE AND METHOD OF USE THEREOF
IL244268A0 (en) Heterocyclic compounds and methods of use
GB2527996B (en) Filter and method of manufacture
PL3019477T3 (pl) Związki heterocykliczne i sposoby ich stosowania
EP2991627A4 (en) BLOOD SUCCANTED COMPOSITION AND METHOD OF USE
PL2988659T3 (pl) Ulepszone sposoby charakterystyki tkanki
GB201309375D0 (en) Medical methods and compounds for medical use
GB201508931D0 (en) Materials and methods for tissue regeneration
GB201310349D0 (en) Composition and method of use thereof
GB201321237D0 (en) Materials and methods for treatment of pulmonary arterial hypertension
GB201301928D0 (en) Composition and method of use thereof
GB201309376D0 (en) Medical methods and compounds for medical use
GB201309379D0 (en) Medical methods and compounds for medical use